Skip to main content
. 2022 Nov 12;2022(4):hoac051. doi: 10.1093/hropen/hoac051

Table II.

Number of studies and range of 12-month period and lifetime infertility prevalence estimates by study descriptors.

Study characteristics Number of studies1
Number and range of 12-month total infertility prevalence estimates (%)2
All studies (studies with 12-month estimates) Number of period estimates3 Period prevalence Number of lifetime estimates3 Lifetime prevalence
Total 133 (84) 69 1.6–34.0 65 3.3–39.7
Methodological approaches
 Prospective TTP design 3 (3) 3 13.6–28.0
 Retrospective TTP design 34 (24) 25 5.0–32.0 15 3.3–35.3
 Current duration design 6 (5) 10 9.4–34.0
 Self-reported infertility measure 61 (39) 16 4.0–18.0 45 4.2–39.7
 Constructed infertility measure 23 (8) 12 6.0–17.0
 Undetermined 13 (6) 3 1.6–13.3 5 10.1–20.9
Definitional characteristics
Numerator (duration only)
 Intentions included4 65 (46) 22 7.0–32.0 42 4.2–39.7
 Intentions not considered 61 (37) 44 1.6–34.0 14 3.3–35.3
Numerator (duration and/or receipt of care included)
 Intentions included4 8 (7) 2 12.0–12.3 8 11.0–26.0
 Intentions not considered 2 (2) 1 18.0 1 35.0
Numerator (subjective evaluation with or without duration)
 Intentions included4 10 (1) 3 11.4–16.4
 Intentions not considered or unknown 10 (1) 1 7.74
Denominator
 All regardless of risk of pregnancy 74 (41) 19 1.6–17.0 35 3.3–35.0
 Ever at risk of pregnancy5 37 (26) 30 4.2–34.0 13 8.2–35.3
 Attempting to conceive4 40 (30) 20 9.4–32.0 17 5.8–39.7
Study population characteristics
Sample type
 General population-based 118 (71) 47 1.6–34.0 65 3.3–39.7
 Clinic-based 15 (13) 22 5.0–28.0
Sex of respondent
 Female 109 (72) 54 1.6–34.0 56 3.3–39.7
 Male 10 (10) 5 7.0–15.3 9 8.2–21.8
 Combined6 18 (9) 10 4.2–28.0
 Not reported 1 (–)
Income Level 7
 High-income countries 70 (55) 43 5.0–34.0 52 4.2–35.3
 Low- and middle-income countries 65 (29) 26 1.6–32.0 13 3.3–39.7
Region 8
 Africa Region 24 (8) 6 9.5–32.0 4 9.3–15.8
 Eastern Mediterranean Region 15 (6) 3 5.2–15.2 4 3.3–21.2
 European Region 47 (37) 32 5.0–34.0 25 9.0–31.8
 South-East Asia Region 12 (–)
 Region of the Americas 24 (15) 16 4.0–15.7 15 4.2–35.3
 Western Pacific Region 29 (19) 12 1.6–28.0 17 8.2–39.7
1

Some studies reported multiple prevalence estimates by applying different definitional or study population characteristics. In these instances, studies were included in more than one tally.

2

12-month estimates of resolved and unresolved infertility. Outlier 12-month infertility estimate is not reported in Table II. Outliers were determined based on their magnitude and justification in the respective studies regarding their ability to capture infertility. Outlier infertility estimates are documented in Supplementary Data S10.

3

Some studies reported multiple prevalence estimates by applying different definitional or study population characteristics. In these instances, multiple estimates from a single study may be included in the same tally.

4

Includes individuals wanting a child and/or trying to conceive.

5

Includes any individual ever at risk of a pregnancy. May include studies that used marital status as a proxy for being at risk of pregnancy.

6

Includes studies that reported estimates for male and female respondents or couple respondents.

7

Defined based on World Bank classifications at the time of the systematic review (The World Bank. Countries and economies. 2021; Available from: https://data.worldbank.org/country).

8

Defined based on World Health Organization regional groupings (World Health Organization. 2022; Available from: https://www.who.int/about/who-we-are/regional-offices).

TTP, time to pregnancy.